Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex Differences in Children and Young Adults With Bicuspid Aortic Valve Disease in First Two Decades of Life.

Mayo Clinic proceedings·2021
Same author

Use of Electrocardiographic Screening to Clear Athletes for Return to Sports Following COVID-19 Infection.

Mayo Clinic proceedings. Innovations, quality & outcomes·2021
Same author

Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.

International journal of cardiology·2020
Same author

Acute Pulmonary Embolism: Contemporary Approach to Diagnosis, Risk-Stratification, and Management.

The International journal of angiology : official publication of the International College of Angiology, Inc·2019
Same author

Vasopressor magnitude predicts poor outcome in adults with congenital heart disease after cardiac surgery.

Congenital heart disease·2018
Same author

Hepatocellular Carcinoma After Fontan Operation: Multicenter Case Series.

Circulation·2018
Same journal

Lyme Carditis and Inflammation-Driven Plaque Erosion Presenting as Sudden Cardiac Arrest.

Texas Heart Institute journal·2025
Same journal

Risk Factors for Development of Stroke in Patients With Continuous-Flow Left Ventricular Assist Device Support as Destination Therapy.

Texas Heart Institute journal·2025
Same journal

Midterm Outcomes of Pediatric Mitral Valvuloplasty for Moderate to Severe Mitral Valve Regurgitation and Associated Risk Factors for Postoperative Deterioration.

Texas Heart Institute journal·2025
Same journal

Navigating the Complexities of Mitral Valve Clipping: Early Severe Mitral Valve Stenosis After Mitral Valve Clipping.

Texas Heart Institute journal·2025
Same journal

The Department of Cardiovascular Anesthesia of The Texas Heart Institute: An Informal History.

Texas Heart Institute journal·2025
Same journal

Contributions of Pathobiological and Translational Science to Understanding and Managing Ischemic Heart Disease: Progress, Impediments, and Future Directions.

Texas Heart Institute journal·2025
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Rituximab-induced polymorphic ventricular tachycardia.

Joseph T Poterucha1, Mark Westberg, Pamela Nerheim

  • 1Department of Internal Medicine & Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA. jpoteruc@unmc.edu

Texas Heart Institute Journal
|April 20, 2010
PubMed
Summary
This summary is machine-generated.

Rituximab, an anti-CD20 antibody for small lymphocytic lymphoma, can cause cardiac arrhythmias. This report details the first known case of symptomatic polymorphic ventricular tachycardia during a rituximab infusion.

Keywords:
Antibodies, monoclonal/administration & dosage/adverse effectscardiac pacing, artificialelectrocardiographyheart ratelong QT syndrome/diagnosis/etiologylymphoma, B-cell/drug therapyrituximabtachycardia, ventricular/chemically induced/mortalitytachycardia/diagnosistorsades de pointes/diagnosis/etiology

More Related Videos

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

Related Experiment Videos

Last Updated: Jun 13, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

Area of Science:

  • Oncology
  • Cardiology
  • Pharmacology

Background:

  • Rituximab is an effective anti-CD20 monoclonal antibody treatment for small lymphocytic lymphoma.
  • Infusion reactions, including cardiac arrhythmias, are known adverse events associated with rituximab therapy.
  • Further investigation into rituximab-related cardiac conduction abnormalities is warranted.

Observation:

  • This report describes a patient experiencing symptomatic polymorphic ventricular tachycardia.
  • The event occurred during the initial infusion of rituximab.
  • This represents the first documented case of this specific adverse reaction.

Findings:

  • Symptomatic polymorphic ventricular tachycardia is a potential, albeit rare, adverse reaction to rituximab.
  • Cardiac conduction abnormalities may be a feature of rituximab-induced infusion reactions.
  • The occurrence during an initial infusion highlights the need for vigilance from the outset of treatment.

Implications:

  • Clinicians should be aware of the potential for severe cardiac arrhythmias during rituximab infusions.
  • Monitoring for cardiac adverse events may be crucial in patients receiving rituximab, especially during initial treatments.
  • This case underscores the importance of continued pharmacovigilance for monoclonal antibody therapies and their associated cardiovascular risks.